← back to search

Qi Miao

China Pharmaceutical University · CN
Area of research
Oncology · Immunology
Research interest
Research interests include CAR-T cell therapy research, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, and Immune cells in cancer.
h-index
17
citations
1,362
works
79
NIH funding
primary concept
Chemistry
email

Recent publications

Advanced gene nanocarriers/scaffolds in nonviral-mediated delivery system for tissue regeneration and repair
Journal of Nanobiotechnology 2024cited by 32position: middledoi
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering
Science Advances 2023cited by 101position: middledoi
BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy
Cancer Immunology Research 2022cited by 47position: middledoi
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells
Journal of Clinical Investigation 2021cited by 245position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2024–2024)Wanheng Zhang · Nantong University1 papers (2024–2024)Nicholas N. Jarjour · University of Minnesota, Twin Cities1 papers (2022–2022)Josué E. Pineda · The University of Texas Health Science Center at Houston1 papers (2022–2022)Brian T. Edelson · Washington University in St. Louis1 papers (2022–2022)Alexander S. Shavkunov · The University of Texas Medical Branch at Galveston1 papers (2022–2022)Ekaterina Esaulova · ITMO University1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2022–2022)Jeffrey P. Ward · Northumbria Healthcare NHS Foundation Trust1 papers (2022–2022)Ken Chen · Teikyo University1 papers (2022–2022)Yongtao Wang · Nantong University1 papers (2024–2024) · 1 papers (2024–2024)Yan Hou · Nantong University1 papers (2024–2024)Avery J. Salmon · The University of Texas Health Science Center at Houston1 papers (2022–2022)Shiyi Yin · China Pharmaceutical University1 papers (2024–2024) · 1 papers (2022–2022)Matthew M. Gubin · The University of Texas MD Anderson Cancer Center1 papers (2022–2022)Reshma Taneja · National University of Singapore1 papers (2022–2022)